We are live on ! Find out more
FPRX

Five Prime Therapeutics, Inc.
FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

Back to rankings

123 hedge funds and large institutions have $490M invested in Five Prime Therapeutics, Inc. in 2018 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 50 increasing their positions, 34 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 34

28% more call options, than puts

Call options by funds: $1.67M | Put options by funds: $1.3M

4% less funds holding

Funds holding: 128 → 123 (-5)

12% less capital invested

Capital invested by funds: $555M → $490M (-$64.8M)

21% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 24

Holders
123
Holders Change
-5
Holders Change %
-3.91%
% of All Funds
2.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
50
Reduced
34
Closed
24
Calls
$1.67M
Puts
$1.3M
Net Calls
+$361K
Net Calls Change
+$1.87M

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$19.7M
2
GPP
Great Point Partners
Connecticut
+$6.84M
3
BlackRock
BlackRock
New York
+$3.67M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.58M
5
Prudential Financial
Prudential Financial
New Jersey
+$2.48M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$21.3M
2
PAMU
Pictet Asset Management (UK)
United Kingdom
-$7.17M
3
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale
Germany
-$4.54M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$3.83M
5
Axa
Axa
France
-$3.79M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$2.78M +$394K +22,572 +15%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$2.53M -$150K -8,586 -5%
Hudson Bay Capital Management
28
Hudson Bay Capital Management
Connecticut
$2.37M +$873K +50,000 +50%
Citadel Advisors
29
Citadel Advisors
Florida
$2.33M +$1.25M +71,683 +95%
VIA
30
Vident Investment Advisory
Georgia
$2.25M +$1.06M +60,608 +74%
Prudential Financial
31
Prudential Financial
New Jersey
$2.25M +$2.48M +142,030 New
Two Sigma Investments
32
Two Sigma Investments
New York
$2.08M +$145K +8,294 +7%
Bank of America
33
Bank of America
North Carolina
$1.59M +$5.86K +336 +0.3%
Morgan Stanley
34
Morgan Stanley
New York
$1.58M +$91.5K +5,245 +6%
PIM
35
Platinum Investment Management
Australia
$1.49M – – –
AGA
36
Altrinsic Global Advisors
Connecticut
$1.42M – – –
State of Wisconsin Investment Board
37
State of Wisconsin Investment Board
Wisconsin
$1.32M -$194K -11,100 -12%
CS
38
Candriam SCA
Luxembourg
$1.26M – – –
TAM
39
Trillium Asset Management
Massachusetts
$1.26M +$7.82K +448 +0.6%
TCIM
40
TIAA CREF Investment Management
New York
$1.09M -$72.4K -4,148 -6%
HH
41
Hilltop Holdings
Texas
$1.03M +$236K +13,500 +26%
ACM
42
Aquilo Capital Management
California
$1.02M +$1.13M +64,881 New
Swiss National Bank
43
Swiss National Bank
Switzerland
$939K – – –
AA
44
ALPS Advisors
Colorado
$808K +$95.5K +5,474 +12%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$803K +$12.2K +699 +1%
ARTA
46
A.R.T. Advisors
New York
$796K -$1.89M -108,400 -68%
AllianceBernstein
47
AllianceBernstein
Tennessee
$789K +$50.3K +2,880 +6%
Los Angeles Capital Management
48
Los Angeles Capital Management
California
$766K +$301K +17,270 +55%
VEA
49
Virtus ETF Advisers
New York
$727K +$172K +9,879 +27%
Jacobs Levy Equity Management
50
Jacobs Levy Equity Management
New Jersey
$695K +$279K +16,000 +57%
1
2
3 4 5

FPRX Hedge Fund Activity: Q2 2018 in Review

123 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q2 2018, worth a combined $490M — down 12% from $555M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of FPRX and 19 opened new positions — a net loss of 5 holders — while 34 trimmed existing stakes and 50 added.

The largest buyer was BVF Inc, opening a new position worth an estimated $19.7M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $21.3M sold.

  • 123 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q2 2018, down from 128 in Q1 2018.
  • Funds reported $490M of Five Prime Therapeutics, Inc. stock for Q2 2018, down 12% quarter-over-quarter.
  • 19 funds opened new Five Prime Therapeutics, Inc. positions in Q2 2018 and 24 closed out, a net change of -5 holders.
  • The largest Five Prime Therapeutics, Inc. buyer in Q2 2018 was BVF Inc, an estimated $19.7M added.
  • The largest Five Prime Therapeutics, Inc. seller in Q2 2018 was EcoR1 Capital, an estimated $21.3M sold.

Based on aggregated 13F filings for Q2 2018.